or transforming growth factor-alpha in human gastric carcinoma cell line MKN-28.

Calcitonin inhibits the growth of human gastric carcinoma cell line KATO III.

Sodium butyrate alters the response of a human colon carcinoma cell line to transforming growth factor-beta 1.

Honokiol induces cell cycle arrest and apoptosis in human gastric carcinoma MGC-803 cell line.

Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture.

Mechanism of inhibitory action of prostaglandins on the growth of human gastric carcinoma cell line KATO III.

Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.

Modulation of the growth and morphology of a human nasopharyngeal carcinoma cell line by growth factors.

In vitro secretion of transforming growth factor alpha (TGF-alpha): a comparison of the A431 cell line with three human oesophageal squamous cell carcinoma lines.

Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line.

Latent form of transforming growth factor-beta 1 acts as a potent growth inhibitor on a human erythroleukemia cell line.

Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1.

Regulation of human colon-carcinoma cell adhesion to extracellular matrix by transforming growth factor beta 1.

Synergistic inhibitory effect of berberine and d-limonene on human gastric carcinoma cell line MGC803.

Characterization of a human endometrial carcinoma cell line producing intraperitoneal tumor growth in immunodeficient mice.

Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line.

Expression of epidermal growth factor receptor and transforming growth factor alpha in human larynx carcinoma.

Transforming growth factor-beta 1 inhibits activation of macrophage cell line RAW 264.7 for cell killing.

Altered gene expression profile after exposure to transforming growth factor β1 in the 253J human bladder cancer cell line.

Cellular kinetics of transforming growth factor-beta induced hemoglobin accumulation in the HEL erythroleukemia cell line.

Detection of colonic growth factors using a human colonic carcinoma cell line (LIM1215).

Epidermal growth factor receptors and EGF-responsiveness of the human breast-carcinoma cell line PMC42.

Production of multiple growth factors by a newly established human thyroid carcinoma cell line.

Effects of the antiestrogen toremifene on growth of the human mammary carcinoma cell line MCF-7.

Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.

Suggest Documents

Calcitonin inhibits the growth of human gastric carcinoma cell line KATO III.

Sodium butyrate alters the response of a human colon carcinoma cell line to transforming growth factor-beta 1.

Honokiol induces cell cycle arrest and apoptosis in human gastric carcinoma MGC-803 cell line.

Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture.

Mechanism of inhibitory action of prostaglandins on the growth of human gastric carcinoma cell line KATO III.

Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.

Modulation of the growth and morphology of a human nasopharyngeal carcinoma cell line by growth factors.

In vitro secretion of transforming growth factor alpha (TGF-alpha): a comparison of the A431 cell line with three human oesophageal squamous cell carcinoma lines.

Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line.

Latent form of transforming growth factor-beta 1 acts as a potent growth inhibitor on a human erythroleukemia cell line.

Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1.

Regulation of human colon-carcinoma cell adhesion to extracellular matrix by transforming growth factor beta 1.

Synergistic inhibitory effect of berberine and d-limonene on human gastric carcinoma cell line MGC803.

Characterization of a human endometrial carcinoma cell line producing intraperitoneal tumor growth in immunodeficient mice.

Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line.

Expression of epidermal growth factor receptor and transforming growth factor alpha in human larynx carcinoma.

Transforming growth factor-beta 1 inhibits activation of macrophage cell line RAW 264.7 for cell killing.

Altered gene expression profile after exposure to transforming growth factor β1 in the 253J human bladder cancer cell line.

Cellular kinetics of transforming growth factor-beta induced hemoglobin accumulation in the HEL erythroleukemia cell line.

Detection of colonic growth factors using a human colonic carcinoma cell line (LIM1215).

Epidermal growth factor receptors and EGF-responsiveness of the human breast-carcinoma cell line PMC42.

Production of multiple growth factors by a newly established human thyroid carcinoma cell line.

Effects of the antiestrogen toremifene on growth of the human mammary carcinoma cell line MCF-7.

Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.

or transforming growth factor-alpha in human gastric carcinoma cell line MKN-28.

Recommend Documents

Follow Us